Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia

Leukemia

Volumn 14, Issue 2, 2000, Pages 316-323

  Eckert, C ^a   Landt, O ^b   Taube, T ^a   Seeger, K ^a   Beyermann, B ^a   Proba, J ^a   Henze, G ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TIB MOLBIOL   (Germany)

Author keywords

Childhood acute lymphoblastic leukemia; LightCycler; MRD; Real time PCR; T cell receptor gene rearrangements

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CLONE; CONTAMINATION; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033983798     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401655     Document Type: Article

References (21)

1. Cave H, van der Werff ten Bosch J, Suciu S, Guidal C, Waterkeyn C, Otten J, Bakkus M, Thielemans K, Grandchamp B, Vilmer E. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group (see comments). New Engl J Med 1998; 339: 591-598.
2. van Dongen JJ, Seriu T, Panzer Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does van den Berg A, Hop WC, Riehm H, Bartram CR. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 352: 1731-1738.
3. Biondi A, Yokota S, Hansen Hagge TE, Rossi V, Giudici G, Maglia O, Basso G, Tell C, Masera G, Bartram CR. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia 1992; 6: 282-288.
4. Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H et al. Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction (see comments). Lancet 1994; 343: 196-200.
5. Knechtli CJ, Goulden NJ, Hancock JP, Harris EL, Garland RJ, Jones CG, Grandage VL, Rowbottom AW, Green AF, Clarke E, Lankester AW, Potter MN, Cornish JM, Pamphilon DH, Steward CG, Oakhill A. Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia. Br J Haematol 1998; 102: 860-871.
6. van Dongen JJ, Szczepanski T, de Bruijn MA, van den Beemd MW, de Bruin Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel Mol EJ, Groeneveld K, Hooijkaas H. Detection of minimal residual disease in acute leukemia patients. Cytok Mol Ther 1996; 2: 121-133.
7. Sczepanski TBA, Pongers-Willemse MJ, Hählen K, Van Wering ER, Wijkhuijs AJM, Tibbe GJM, De Bruijn MAC, Van Dongen JJM. Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia 1999; 13: 196-205.
8. Seriu T, Erz D, Stark Y, Bartram CR. T cell receptor Dδ2 Dδ3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 759-761.
9. Ouspenskaia MVJD, Roberts WM, Estrov Z, Zipf TF. Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia 1995; 9: 321-328.
10. Sykes PJNS, Brisco MJ, Hughes E, Condon J, Morley AA. Quantitation of targets of PCR by use of limiting dilution. Biotechniques 1992; 13: 444-449.
11. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaisir N, d'Auriol L et al. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes. Blood 1994; 83: 1892-1902.
12. Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ, Wijkhuijs AJ, de Haas V, Roovers E, van der Schoot CE, van Dongen JJ. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 1998; 12: 2006-2014.
13. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-994.
14. Mensink E, van de Locht A, Schattenberg A, Linders E, Schaap N, Geurts van Kessel A, De Witte T. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR. Br J Haematol 1998; 102: 768-774.
15. Kreuzer KA, Lass U, Bohn A, Landt O, Schmidt CA. LightCycler Technology for the quantification of bcr/abl fusion transcripts. Cancer Res 1999; 59: 3171-3174.
16. Taube T, Seeger K, Beyermann B, Hanel C, Duda S, Linderkamp C, Henze G. Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALL. Leukemia 1997; 11: 1978-1982.
17. Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 1997; 245: 154-160.
18. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997; 22: 130-131.
19. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991; 88: 7276-7280.
20. Caplin BERR, Bernard PS, Wittwer CT. The most direct way to monitor PCR amplification and mutation detection. Biochemica 1999; 1: 5-8.
21. De Silva DRA, Herrmann M, Tabiti K, Wittwer C. Rapid genotyping and quantification on the LightCycler with hybridization probes. Biochemica Information 1998; 102: 9-12.